United InnoMed

United InnoMed® was founded in 2020, focusing on the development of innovative Class III active implantable products, and is committed to providing cost-effective "closed-loop" heart failure management solutions for heart failure patients worldwide. At present, the products under research cover the management of both acute and chronic heart failure patients, mainly including: ① Long-term implantable products integrating "treatment + diagnosis" for chronic heart failure patients; ② Short-term electrical circulatory support (Electrical Circulatory Support) for acute heart failure inpatients. Both products have completed dozens of animal experiments and are initiating clinical trials for registration in China.